InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: elllk post# 26749

Thursday, 10/15/2020 6:52:00 PM

Thursday, October 15, 2020 6:52:00 PM

Post# of 44690
They appear to be 'all in' that data from the 102 patients' of the 150 2b-Trial will do and then developing the market thru IPO / merger / partnering / subcontracting.?.
With NRX a different private company how are 'Profits' to be measured for the splitting the 50-50/85-15% agreement? Overhead? Getting complicated for the common shareholders to see when a 'profit' is made, IMO.

But. If we're lucky, IMO, maybe an actual Biggie will want the whole group package at a price. Bonu$E$, C-O-C and Jobs for the top dudes, of course.

A choice from the above needs to be done ASAP as we all see the many avenues working on the COVID issue. Time=$ and lives. The Cocktail of drugs' has gained support lately, IMO. Only two VIP drugs in Trials using different MOAs. So many folks chasing Mabs/antibodies/virs. It's good to be one of two with this VIP approach.
Not buying more yet or flipping.